{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:12:59Z","timestamp":1792059179048,"version":"4.4.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Urol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0970-1591.109975","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T02:43:30Z","timestamp":1364957010000},"page":"2","source":"Crossref","is-referenced-by-count":52,"title":["The use of botulinum toxin for the treatment of overactive bladder syndrome"],"prefix":"10.4103","volume":"29","author":[{"given":"Bogdan","family":"Orasanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangeetaT","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0970-1591.109975-1","first-page":"S169","volume-title":"Clinical trials of botulinum toxin in the treatment of spasticity","author":"Simpson","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"key-10.4103\/0970-1591.109975-2","doi-asserted-by":"crossref","unstructured":"Kleeman SD, Karram MM. Overactive bladder syndrome and nocturia. In: Walters MD, Karam MM, editors. Urogynecology and reconstructive pelvic surgery. 3 rd ed. Philadelphia: Mosby; 2007.","DOI":"10.1016\/B978-0-323-02902-5.50034-4"},{"key":"key-10.4103\/0970-1591.109975-3","first-page":"1177","volume-title":"Practical aspects of life style modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence","author":"Wyman","year":"2009","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/0970-1591.109975-4","doi-asserted-by":"crossref","unstructured":"van Ermengem E. Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as \"Ueber einen neuen ana\u00ebroben Bacillus und seine Beziehungen zum Botulismus\" in Zeitschrift f\u00fcr Hygiene und Infektionskrankheiten 26: 1-56, 1897. Rev Infect Dis 1979;1:701-19.","DOI":"10.1093\/clinids\/1.4.701"},{"key":"key-10.4103\/0970-1591.109975-5","doi-asserted-by":"crossref","unstructured":"Mahajan ST, Brubaker L. Botulinum toxin: From life-threatening disease to novel medical therapy. Am J Obstet Gynecol 2007;196:7-15.","DOI":"10.1016\/j.ajog.2006.03.108"},{"key":"key-10.4103\/0970-1591.109975-6","first-page":"714","volume-title":"Treatment of anismus in intractable constipation with botulinum A toxin","author":"Hallan","year":"1988","journal-title":"Lancet"},{"key":"key-10.4103\/0970-1591.109975-7","unstructured":"Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/103000s5232lbl.pdf. Last accessed february 17, 2013."},{"key":"key-10.4103\/0970-1591.109975-8","first-page":"23479","volume-title":"Botulinum neurotoxins are zinc proteins","author":"Schiavo","year":"1992","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0970-1591.109975-9","first-page":"135","volume-title":"Botulinum neurotoxin type E: Studies on the mechanism of action and on structure activity relationships","author":"Simpson","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0970-1591.109975-10","first-page":"16","volume-title":"Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction","author":"Simpson","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0970-1591.109975-11","unstructured":"Dolly J. General properties and cellular mechanisms of neurotoxins. In: Jankovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994."},{"key":"key-10.4103\/0970-1591.109975-12","first-page":"457","volume-title":"Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalisation","author":"Dolly","year":"1984","journal-title":"Nature"},{"key":"key-10.4103\/0970-1591.109975-13","first-page":"24","volume-title":"Treatment of detrusor sphincter dyssynergia with botulinum A toxin","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehab"},{"key":"key-10.4103\/0970-1591.109975-14","first-page":"964","volume-title":"Motor nerve sprouting in human orbicularis muscle after botulinum A injection","author":"Holds","year":"1990","journal-title":"Invest Opthalmol Vis Sci"},{"key":"key-10.4103\/0970-1591.109975-15","first-page":"217","volume-title":"A comparison of botulinum toxin and saline for the treatment of chronic anal fissure","author":"Maria","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0970-1591.109975-16","first-page":"552","volume-title":"Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity","author":"Sahai","year":"2010","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.109975-17","first-page":"213","volume-title":"Development of resistance to botulinum toxin type A in patients with torticollis","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"key":"key-10.4103\/0970-1591.109975-18","doi-asserted-by":"crossref","unstructured":"Greene P, Fahn S. Development on antibodies to botulinum toxin type A in patients with torticollis treated with injections of botulinum toxin type A. In: Dasgupta B, editor. Boutlinum and tetanus neurotoxins: Neurotransmission and biomedical aspects. New York: Plenum Press; 1993.","DOI":"10.1007\/978-1-4757-9542-4_72"},{"key":"key-10.4103\/0970-1591.109975-19","first-page":"1440","volume-title":"Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia","author":"Ansved","year":"1997","journal-title":"Neurology"},{"key":"key-10.4103\/0970-1591.109975-20","first-page":"165","volume-title":"Botulinum toxin as a new therapy option for voiding disorders: Current state of the art","author":"Leippold","year":"2003","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-21","first-page":"880","volume-title":"Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection","author":"Smith","year":"2005","journal-title":"J Endourol"},{"key":"key-10.4103\/0970-1591.109975-22","first-page":"100","volume-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: A European consensus report","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-23","first-page":"599","volume-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","author":"Wyndaele","year":"2002","journal-title":"Spinal Cord"},{"key":"key-10.4103\/0970-1591.109975-24","first-page":"567","volume-title":"Botulinum toxin therapy for neurogenic detrusor overactivity","author":"Smaldone","year":"2010","journal-title":"Urol Clin North Am"},{"key":"key-10.4103\/0970-1591.109975-25","first-page":"275","volume-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: A systematic literature review","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-26","first-page":"919","volume-title":"Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: Risk factors and influence on treatment outcome.Eur Urol","author":"Kuo","year":"2010","journal-title":""},{"key":"key-10.4103\/0970-1591.109975-27","unstructured":"Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/103000s5109s5210lbl.pdf. Last accessed february 17, 2013."},{"key":"key-10.4103\/0970-1591.109975-28","first-page":"323","volume-title":"Botulinum toxin type A (BOTOX) for treatment of migraine","author":"Binder","year":"2002","journal-title":"Dis Mon"},{"key":"key-10.4103\/0970-1591.109975-29","first-page":"2131","volume-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-30","first-page":"692","volume-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs.Preliminary results?","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-31","first-page":"642","volume-title":"Botulinum Toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients","author":"Deffontaines-Rufin","year":"2011","journal-title":"Int Braz J Urol"},{"key":"key-10.4103\/0970-1591.109975-32","first-page":"960","volume-title":"Botulinum toxin type A in patients with Parkinson\u2032s disease and refractory overactive bladder","author":"Giannantoni","year":"2011","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-33","first-page":"2229","volume-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: A randomized, double-blind trial","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-34","first-page":"1344","volume-title":"Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis","author":"Khan","year":"2011","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-35","first-page":"659","volume-title":"Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia","author":"Chen","year":"2011","journal-title":"Spinal Cord"},{"key":"key-10.4103\/0970-1591.109975-36","first-page":"655","volume-title":"Injections of botulinum toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury","author":"Chen","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/0970-1591.109975-37","first-page":"385","volume-title":"Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany","author":"Wefer","year":"2010","journal-title":"World J Urol"},{"key":"key-10.4103\/0970-1591.109975-38","first-page":"379","volume-title":"Treatment of neurogenic detrusor overactivity with botulinum toxin A: The first seven years","author":"Stoehrer","year":"2009","journal-title":"Urol Int"},{"key":"key-10.4103\/0970-1591.109975-39","first-page":"1246","volume-title":"Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction","author":"Pannek","year":"2009","journal-title":"BJU Int"},{"key":"key-10.4103\/0970-1591.109975-40","first-page":"805","volume-title":"Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent.Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity?","author":"Ghalayini","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/0970-1591.109975-41","first-page":"705","volume-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-42","first-page":"335","volume-title":"Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: A randomised, placebo-controlled, double-blind study","author":"Ehren","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"key-10.4103\/0970-1591.109975-43","first-page":"850","volume-title":"Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence","author":"Schurch","year":"2007","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-44","first-page":"11","volume-title":"Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore","author":"Tow","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"key-10.4103\/0970-1591.109975-45","first-page":"1193","volume-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.109975-46","first-page":"653","volume-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity incontinence","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-47","first-page":"37","volume-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.109975-48","first-page":"196","volume-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic incontinence: Results of a single treatment, randmized, placebo controlled 6-month study","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-49","first-page":"510","volume-title":"European experience of 200 cases treated with bolutlinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-50","unstructured":"Available from: http:\/\/agn.client.shareholder.com\/releasedetail.cfm?ReleaseID=600958. Last accessed february 17, 2013."},{"key":"key-10.4103\/0970-1591.109975-51","first-page":"520","volume-title":"Efficacy and safety of low doses of botulinum toxin type A for the treatment of refractory idiopathic overactive bladder: A multicenter, double-blind, randomized, placebo-controlled dose-ranging study","author":"Denys","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.109975-52","first-page":"556","volume-title":"Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder","author":"Rovner","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"key-10.4103\/0970-1591.109975-53","first-page":"714","volume-title":"Botulinum toxin a for idiopathic detrusor overactivity","author":"Lie","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"key-10.4103\/0970-1591.109975-54","first-page":"153","volume-title":"Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children","author":"Marte","year":"2010","journal-title":"Eur J Pediatr Surg"},{"key":"key-10.4103\/0970-1591.109975-55","first-page":"1509","volume-title":"Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: Results from a randomized double-blind placebo-controlled trial","author":"Sahai","year":"2009","journal-title":"BJU Int"},{"key":"key-10.4103\/0970-1591.109975-56","first-page":"217","volume-title":"Pelvic Floor Disorders Network.Refractory idiopathic urge urinary incontinence and botulinum A injection","author":"Brubaker","year":"2008","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-57","first-page":"182","volume-title":"Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience","author":"Mohanty","year":"2008","journal-title":"Indian J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0970-1591","issn-type":"print"},{"key":"key-10.4103\/0970-1591.109975-58","first-page":"1302","volume-title":"Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity","author":"Jeffery","year":"2007","journal-title":"BJU Int"},{"key":"key-10.4103\/0970-1591.109975-59","first-page":"177","volume-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","author":"Schmid","year":"2006","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.109975-60","first-page":"1735","volume-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: A prospective nonrandomized study","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"}],"container-title":["Indian Journal of Urology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:22:04Z","timestamp":1786648924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0970-1591.109975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["109975"],"URL":"https:\/\/doi.org\/10.4103\/0970-1591.109975","relation":{},"ISSN":["0970-1591"],"issn-type":[{"value":"0970-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}